CARILION NEW RIVER VALLEY MED CENTER
1. Target Overview & Investment Thesis
CARILION NEW RIVER VALLEY MED CENTER is a 94-bed suburban community hospital in MONTGOMERY, VA with $261.3M in net patient revenue and a -0.5% operating margin. The hospital serves a payer mix of 35.4% Medicare, 3.7% Medicaid, and 60.9% commercial.
Thesis: Turnaround. Our ML models identify $19.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.5% to 6.9% (+736bps).
| Net Revenue HCRIS | $261.3M |
| Current EBITDA COMPUTED | $-1.2M |
| Operating Margin COMPUTED | -0.5% |
| Occupancy HCRIS | 84.4% |
| Revenue / Bed COMPUTED | $2.8M |
| Net-to-Gross HCRIS | 28.8% |
| Distress Probability ML | 38.1% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of -0.5% places it below the state median. Among 53 size-comparable peers (47-188 beds), the median margin is 7.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (47-188), prioritizing same-state peers. 53 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CARILION NEW RIVER VALLEY MED (Target) | VA | 94 | $261.3M | -0.5% |
| INOVA FAIR OAKS HOSPITAL | VA | 174 | $382.5M | 28.5% |
| SENTARA MARTHA JEFFERSON HOSPI | VA | 150 | $362.0M | -6.4% |
| SENTARA PRINCESS ANNE HOSPITAL | VA | 174 | $361.5M | 10.3% |
| MARYVIEW HOSPITAL | VA | 160 | $348.0M | -2.5% |
| ST. FRANCIS MEDICAL CENTER | VA | 128 | $339.6M | 8.6% |
| SENTARA OBICI HOSPITAL | VA | 186 | $329.1M | 15.1% |
| SENTARA CAREPLEX HOSPITAL | VA | 169 | $302.5M | 9.3% |
| SENTARA NORTHERN VIRGINIA MED | VA | 147 | $286.3M | -4.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $5.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $5.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $5.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $167K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-1.2M |
| + RCM Uplift | +$19.2M |
| Pro Forma EBITDA | $18.0M |
| Current Margin | -0.5% |
| Pro Forma Margin | 6.9% |
| WC Released (1x) | $10.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-1.8M | $184.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-1.8M | $202.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-1.7M | $265.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-1.7M | $288.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-2.0M | $88.9M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-2.0M | $97.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 53 hospitals with 47-188 beds
- Same-state prioritization (n=54)
- Comp margins: P25=-6.4% / P50=7.3% / P75=15.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.